Status:
RECRUITING
Zinc Oxide VS MEBO
Lead Sponsor:
King Abdullah Medical City
Conditions:
Pressure Injury
Pressure Injury Stage 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.
Detailed Description
In this study the subject will be randomized using electronic randomization 1:1 ratio. The randomization list was generated electronically through R using the Random Allocation Rule. The data will be ...
Eligibility Criteria
Inclusion
- Willing to participate.
- KAMC cases in medical ward, neuroscience ward, and intensive care unit.
- Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel/national pressure ulcer advisory panel (NPUAP) guidelines.
Exclusion
- Not consenting to participate
- Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients.
- Either a category III or IV pressure ulcer.
- Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage).
- Signs of wound infection (pus draining from the ulcer, a foul-smelling odour, tenderness, heat and increased redness in the surrounding skin and fever).
- Patients who undertaking other therapies that could affect healing, such as corticosteroids, radiation therapy, or chemotherapy for cancer.
- Heavy smoking (more than 20 cigarettes a day).
- Concomitant chronic disease (e.g., diabetes mellitus or frank vascular disease such as Buerger's disease).
- Patients who unable to continue the study because of death, discharge, or change in the care setting.
Key Trial Info
Start Date :
December 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT07193849
Start Date
December 31 2023
End Date
December 31 2025
Last Update
September 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
King Abdulla Medical City in Holy capital
Mecca, Western Reagan, Saudi Arabia, 24211
2
King Abdulla Medical City in Holy capital
Mecca, Western Reagan, Saudi Arabia, 24211